The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM

Nature

Volumn 395, Issue 6701, 1998, Pages 462-469

  Sayos, J ^a   Wu, C ^a   Morra, M ^a   Wang, N ^a   Zhang, X ^a   Allen, D ^a   Van Schaik, S ^a   Notarangelo, L ^b   Geha, R ^c   Roncarolo, M G ^d   Oettgen, H ^c   De Vries, J E ^e   Aversa, G ^e   Terhorst, C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF BRESCIA   (Italy)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^e Novartis Forsch Inst G   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIGEN; T LYMPHOCYTE ANTIGEN;

ARTICLE; B LYMPHOCYTE; EPSTEIN BARR VIRUS; GENE MUTATION; HUMAN; LYMPHOPROLIFERATIVE DISEASE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; X CHROMOSOME LINKED DISORDER;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; BASE SEQUENCE; CARRIER PROTEINS; CELLS, CULTURED; CHROMOSOME MAPPING; CLONING, MOLECULAR; COS CELLS; DNA; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JURKAT CELLS; LYMPHOPROLIFERATIVE DISORDERS; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-FYN; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; T-LYMPHOCYTES; TISSUE DISTRIBUTION; X CHROMOSOME;

HUMAN HERPESVIRUS 4;

EID: 0032190081     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/26683     Document Type: Article

References (23)

1. Cocks, B. G. et al. A novel receptor involved in T-cell activation. Nature 376, 260-263 (1995).
2. Aversa, G. et al. SLAM and its role in T cell activation and Th cell responses. Immunol. Cell Biol. 75, 202-205 (1997).
3. Aversa, G., Chang, C. J., Carballido, J. M., Cocks, B. G. & de Vries, J. E. Engagement of the signalling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production. J. Immunol. 158, 4036-4044 (1997).
4. Carballido, J. M. et al. Reversal of human allergic T helper 2 responses by engagement of signaling lymphocytic activation molecule. J. Immunol. 159, 4316-4321 (1997).
5. Isomaki, P. et al. Increased expression of signaling lymphocytic activation molecule in patients with rheumatoid arthritis and its role in the regulation of cytokine production in rheumatoid synovium. J. Immunol. 159, 2986-2993 (1997).
6. Punnonen, J. et al. Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J. Exp. Med. 185, 993-1004 (1997).
7. Ferrante, P. et al. Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis. J. Immunol. 160, 1514-1521 (1998).
8. Lamartine, I. et al. Physical map and cosmid contig encompassing a new interstitial deletion of the X-linked lymphoproliferative syndrome region. Eur. J. Hum. Genet. 4, 342-351 (1996).
9. Porta, G. 4.5-Mb YAC STS contig 50-kb resolution, spanning Xq25 deletions in two patients with lymphoproliferative syndrome. Genome Res. 7, 27-36 (1997).
10. Lanyi, A. et al. A yeast artificial chromosome (YAC) contig encompassing the critical region of the X-linked lymphoproliferative disease (XLP) locus. Genomics 39, 55-56 (1997).
11. Purtilo, D. T. Immunopathology of X-linked lymphoproliferative syndrome. Immunol. Today 4, 291-295 (1983).
12. Seemayer, T. A. et al. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr. Res. 38, 471-478 (1995).
13. Rousset, F., Souillet, G., Roncarolo, M. G. & Lamelin, J.-P. Studies of EBV-lymphoid cell interactions with the X-linked lymphoproliferative syndrome: normal EBV-specific HLA-restricted cytotoxidty. Clin. Exp. Immunol. 63, 280-289 (1986).
14. Cooper, D. M. & Krawczak, M. Human Gene Mutations (Bios Scientific, Oxford, 1993).
15. Marengere, L. E. et al. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 272, 1170-1173 (1996).
16. Sutkowski, N. et al. An Epstein-Barr virus-associated superantigen. J. Exp. Med. 184, 971-800 (1996).
17. + T-helper and a T-killer cell. Nature 393, 474-478 (1998).
18. Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R. & Melief, C. J. M. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393, 480-483 (1998).
19. Bennett, S. R. M. et al. Help for cytotoxk-T-cell responses is mediated by CD40 signalling. Nature 393, 478-480 (1998).
20. Ramesh, N., Anton, I. M., Hartwig, I. H. & Geha, R. S. WIP, a protein associated with Wiskott-Aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells. Proc. Natl Acad. Sci. USA 94, 14671-14676 (1997).
21. Wang, B. et al. Over-expression of CD3-∈ transgenes blocks T lymphocyte development. Intl. Immunol. 7, 435-448 (1995).
22. de Aos, I. et al. Tyrosine phosphorylation of the CD3-epsilon subunit of the T cell antigen receptor mediates enhanced association with phosphatidylinositol 3-kinase in Jurkat cells. J. Biol. Chem. 40, 25310-25318 (1997).
23. Martinez-Martinez, S. et al. Blockade of T-cell activation by dithiocarbamates involves novel mechanisms of inhibition of nuclear factor of activated T cells. Mol. Cell. Biol. 17, 6437-6447 (1997).